Intezyne Technologies Announces Formation of Its Clinical Advisor Board TAMPA, Fla., Jan. 9, 2015 (GLOBE NEWSWIRE) -- Intezyne Technologies, a privately held drug development company dedicated to improving the treatment of cancer, announced it has formed the Intezyne...

Intezyne Technologies Expands Executive Leadership Team With Two Key Appointments - Carolyn Paradise, MD, Joins Intezyne as Acting Chief Medical Officer - - Tim Coan Joins Intezyne as Chief Financial Officer - TAMPA, Fla., July 10, 2014 (GLOBE NEWSWIRE) -- Intezyne...

Intezyne Technologies Expands Its Oncology Pipeline Through Strategic Acquisition of Niiki Pharma Niiki Pharma brings two first-in-class clinical-stage oncology products to Intezyne Intezyne's product pipeline now includes one Phase 2-ready compound, one Phase 1-ready compound, one...